AT MULTITARGET THERAPEUTICS
Onegene Biotechnology is pioneering multi-target therapeutics to create breakthrough medicines that will
transform the lives of people with complex and chronic diseases.
Our platform can generate highly potent tri- or tetra-specific protein-based drugs using different therapeutic modalities. With unprecedented design flexibility and optimal physical properties, Onegene Biotechnology is opening a new design space for multi-specific protein drugs.MORE
The programs in our portfolio are focused on treating complex and multifactorial diseases where multi-target medicines can provide prolonged holistic benefits. Our core portfolio currently consists of NASH, fibrotic diseases and immuno-oncology programs.MORE